trending Market Intelligence /marketintelligence/en/news-insights/trending/BzfqJI657iJLq7OVqLL9hA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Lilly to buy back $2B in outstanding debt

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Lilly to buy back $2B in outstanding debt

Eli Lilly and Co. is buying back up to $2 billion of its outstanding debt via a cash tender offer.

Under the tender offer, the pharmaceutical giant will buy its outstanding 3.950% notes due 2047, 3.700% notes due 2045, 3.875% notes due 2039, 7.125% notes due 2025, 6.77% notes due 2036, 5.950% notes due 2037 and 5.55% notes due 2037.

Lilly will also purchase its outstanding 5.50% notes due 2027, 4.650% notes due 2044, 3.100% notes due 2027, 2.750% notes due 2025, 3.375% notes due 2029, 3.950% notes due 2049, 4.150% notes due 2059 and 2.350% notes due 2022.

The tender offer will expire at 11:59 p.m. New York City time on Nov. 21, unless extended or terminated earlier.

Citigroup Global Markets Inc. and Morgan Stanley & Co. LLC are lead dealer managers for the tender offer, while BNP Paribas Securities Corp. and J.P. Morgan Securities LLC are co-dealer managers. Global Bondholder Services Corp. is the tender and information agent for the tender offer.